StonvexLoading…
StonvexStonvexStonvexA securities class action lawsuit has been filed against Immutep Ltd. (NASDAQ: IMMP) alleging the company made false and misleading statements about its TACTI004 trial, concealing negative internal data while publicly claiming the trial was on track. Investors who purchased ADRs between March 24, 2025 and March 12, 2026 may be eligible for compensation, with a lead plaintiff deadline of July 6, 2026.
A securities class action lawsuit has been filed against Immutep Ltd. (NASDAQ: IMMP) for allegedly making false and misleading statements about the TACTI004 trial. The company reportedly concealed negative information about the trial's prospects while publicly stating it was on track, despite internal data suggesting increased risk of failure. Investors who purchased ADRs between March 24, 2025 and March 12, 2026 may be eligible for compensation, with a lead plaintiff deadline of July 6, 2026.
Summary and sentiment are generated by AI for educational purposes. Always verify with the original source before making investment decisions.
Risk warning
Investing in equities carries significant risk, including the potential loss of your entire investment. Volatility, liquidity, geopolitical, and currency risks can all materially affect outcomes. Past performance does not guarantee future results. Nothing on Stonvex is investment advice, a recommendation, or a solicitation to buy or sell any security. Stonvex is not a registered investment advisor (RIA), broker-dealer, or financial planner. You should consult a licensed advisor before making investment decisions and only invest capital you can afford to lose.
© 2026 Stonvex. All rights reserved.
Service not available to residents of: Belarus, China, Cuba, France, Germany, India, Iran, Japan, North Korea, Russia, South Korea, Sudan, Syria. See Terms. You must be 18 years or older to use this service.